Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Near-infrared ICG imaging vs lymphoscintigraphy for sentinel lymph node detection in breast cancer
2013-001555-12Phase 2Completed
- Sponsor
- Institut Jules Bordet
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of indocyanine green in breast cancer, sponsored by Institut Jules Bordet. Primary endpoints: Detection rate of sentinel lymph nodes using ICG near-infrared imaging, False negative rate of sentinel lymph node detection with ICG and 1 more. Started Jun 2013; status: completed.
02
Drugs
indocyanine green
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2013-001555-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001555-12.